Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial.
Munoz FM, Bond NH, Maccato M, Pinell P, Hammill HA, Swamy GK, Walter EB, Jackson LA, Englund JA, Edwards MS, Healy CM, Petrie CR, Ferreira J, Goll JB, Baker CJ.
JAMA. 2014 May 7;311(17):1760-9. doi: 10.1001/jama.2014.3633.
Identification of Formaldehyde-Induced Modifications in Diphtheria Toxin.
Metz B, Michiels T, Uittenbogaard J, Danial M, Tilstra W, Meiring HD, Hennink WE, Crommelin DJA, Kersten GFA, Jiskoot W.
J Pharm Sci. 2020 Jan;109(1):543-557. doi: 10.1016/j.xphs.2019.10.047. Epub 2019 Oct 31.
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine.
Peterson JT, Zareba AM, Fitz-Patrick D, Essink BJ, Scott DA, Swanson KA, Chelani D, Radley D, Cooper D, Jansen KU, Dormitzer PR, Gruber WC, Gurtman A.
J Infect Dis. 2022 Jun 15;225(12):2077-2086. doi: 10.1093/infdis/jiab505.
Infant vaccine co-administration: review of 18 years of experience with GSK's hexavalent vaccine co-administered with routine childhood vaccines.
Dolhain J, Janssens W, Dindore V, Mihalyi A.
Expert Rev Vaccines. 2020 May;19(5):419-443. doi: 10.1080/14760584.2020.1758560. Epub 2020 May 18.
Clinical trials of the Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine.
Lepow M.
Pediatr Infect Dis J. 1987 Aug;6(8):804-7. doi: 10.1097/00006454-198708000-00042.
Safety and immunogenicity of conjugate vaccine for typhoid (Vi-DT): Finding from an observer-blind, active-controlled, randomized, non-inferiority, phase III clinical trial among healthy volunteers.
Tamrakar D, Poudel P, Thapa P, Singh S, Khadgi A, Thapa S, Tamrakar R, Shrestha A, Madhup S, Rai GK, Gupta BP, Saluja T, Sahastrabuddhe S, Shrestha R.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2301631. doi: 10.1080/21645515.2023.2301631. Epub 2024 Jan 8.
Reduced-antigen combined diphtheria-tetanus-acellular pertussis vaccine (Boostrix).
Chapman TM, Goa KL.
Drugs. 2003;63(13):1407-13; discussion: 1415-6. doi: 10.2165/00003495-200363130-00005.
Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix): a review of its properties and use as a single-dose booster immunization.
McCormack PL.
Drugs. 2012 Sep 10;72(13):1765-91. doi: 10.2165/11209630-000000000-00000.
Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines.
Deforest A, Long SS, Lischner HW, Girone JA, Clark JL, Srinivasan R, Maguire TG, Diamond SA, Schiller RP, Rothstein EP, et al.
Pediatrics. 1988 Feb;81(2):237-46.
A review of the safety of vaccines used in routine immunization in Africa.
Yamoah P, Bangalee V, Oosthuizen F.
Afr Health Sci. 2020 Mar;20(1):227-237. doi: 10.4314/ahs.v20i1.28.
